Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1968 1
1969 1
1970 1
1971 1
1973 2
1974 3
1976 2
1977 1
1979 1
1982 2
1983 6
1984 2
1985 5
1986 2
1987 3
1988 3
1989 5
1990 3
1991 1
1992 2
1993 9
1994 4
1995 11
1996 1
1997 6
1998 4
1999 9
2000 10
2001 7
2002 11
2003 13
2004 26
2005 13
2006 19
2007 21
2008 18
2009 16
2010 31
2011 31
2012 22
2013 39
2014 29
2015 20
2016 28
2017 41
2018 22
2019 33
2020 109
2021 125
2022 97
2023 55
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

860 results

Results by year

Filters applied: . Clear all
Page 1
How common is intersex? a response to Anne Fausto-Sterling.
Sax L. Sax L. J Sex Res. 2002 Aug;39(3):174-8. doi: 10.1080/00224490209552139. J Sex Res. 2002. PMID: 12476264 Review.
Anne Fausto-Sterling s suggestion that the prevalence of intersex might be as high as 1.7% has attracted wide attention in both the scholarly press and the popular media. ...Applying this more precise definition, the true prevalence of intersex is seen to be about 0.018%, …
Anne Fausto-Sterling s suggestion that the prevalence of intersex might be as high as 1.7% has attracted wide attention in both the s …
Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia.
Vilar L, Vilar CF, Lyra R, Freitas MDC. Vilar L, et al. Neuroendocrinology. 2019;109(1):7-19. doi: 10.1159/000499694. Epub 2019 Mar 20. Neuroendocrinology. 2019. PMID: 30889571 Free article. Review.
Up to 40% of macroprolactinemic patients may present with hypogonadism symptoms, infertility, and/or galactorrhea. Thus, the screening for macroprolactin is indicated not only for asymptomatic subjects but also for those without an obvious cause for their prolactin (PRL) e …
Up to 40% of macroprolactinemic patients may present with hypogonadism symptoms, infertility, and/or galactorrhea. Thus, the screenin …
Gynecomastia.
Dickson G. Dickson G. Am Fam Physician. 2012 Apr 1;85(7):716-22. Am Fam Physician. 2012. PMID: 22534349 Free article. Review.
Nonphysiologic gynecomastia may be caused by chronic conditions (e.g., cirrhosis, hypogonadism, renal insufficiency); use of medications, supplements, or illicit drugs; and, rarely, tumors. ...
Nonphysiologic gynecomastia may be caused by chronic conditions (e.g., cirrhosis, hypogonadism, renal insufficiency); use of medicati …
Testosterone and obesity.
Kelly DM, Jones TH. Kelly DM, et al. Obes Rev. 2015 Jul;16(7):581-606. doi: 10.1111/obr.12282. Epub 2015 May 15. Obes Rev. 2015. PMID: 25982085 Review.
Testosterone replacement may therefore potentially be an effective adjunctive treatment for weight management in obese men with concomitant hypogonadism....
Testosterone replacement may therefore potentially be an effective adjunctive treatment for weight management in obese men with concomitant …
[Management of chemotherapy side effects and their long-term sequelae].
Zraik IM, Heß-Busch Y. Zraik IM, et al. Urologe A. 2021 Jul;60(7):862-871. doi: 10.1007/s00120-021-01569-7. Epub 2021 Jun 29. Urologe A. 2021. PMID: 34185118 Review. German.
The most common therapy regimens are BEP (cisplatin, etoposide, bleomycin), carboplatin mono (AUC 7), PEI (cisplatin, etoposide, ifosfamide), TIP (cisplatin, ifosfamide, paclitaxel) and GOP (gemcitabine, oxaliplatin, paclitaxel). ...Since young men are usually affected, th …
The most common therapy regimens are BEP (cisplatin, etoposide, bleomycin), carboplatin mono (AUC 7), PEI (cisplatin, etoposide, ifos …
Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.
Solomon ZJ, Mirabal JR, Mazur DJ, Kohn TP, Lipshultz LI, Pastuszak AW. Solomon ZJ, et al. Sex Med Rev. 2019 Jan;7(1):84-94. doi: 10.1016/j.sxmr.2018.09.006. Epub 2018 Nov 30. Sex Med Rev. 2019. PMID: 30503797 Free PMC article. Review.
Early clinical studies have demonstrated potential uses for SARMs in the treatment of cancer-related cachexia, benign prostatic hyperplasia (BPH), hypogonadism, and breast cancer, with positive results. CONCLUSION: SARMs have numerous possible clinical applications, with p …
Early clinical studies have demonstrated potential uses for SARMs in the treatment of cancer-related cachexia, benign prostatic hyperplasia …
Neurological complications of coronavirus and COVID-19.
Carod-Artal FJ. Carod-Artal FJ. Rev Neurol. 2020 May 1;70(9):311-322. doi: 10.33588/rn.7009.2020179. Rev Neurol. 2020. PMID: 32329044 Free article. Review. English, Spanish.
Neurological symptoms have been reported in patients affected by COVID-19, such as headache, dizziness, myalgia and anosmia, as well as cases of encephalopathy, encephalitis, necrotising haemorrhagic encephalopathy, stroke, epileptic seizures, rhabdomyolysis and Guillain-B …
Neurological symptoms have been reported in patients affected by COVID-19, such as headache, dizziness, myalgia and anosmia, as well …
Neurological Sequelae of COVID-19.
Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Ahmad SJ, et al. J Integr Neurosci. 2022 Apr 6;21(3):77. doi: 10.31083/j.jin2103077. J Integr Neurosci. 2022. PMID: 35633158 Free article. Review.
The various neurological disorders associated with COVID-19 range in severity from mild symptoms such as headache, or myalgias to more severe symptoms such as stroke, psychosis, and anosmia. While some of the COVID-19 associated neurological complications are mild and reve …
The various neurological disorders associated with COVID-19 range in severity from mild symptoms such as headache, or myalgias to more sever …
Hyperprolactinemia: pathophysiology and therapeutic approach.
Capozzi A, Scambia G, Pontecorvi A, Lello S. Capozzi A, et al. Gynecol Endocrinol. 2015 Jul;31(7):506-10. doi: 10.3109/09513590.2015.1017810. Epub 2015 Jul 6. Gynecol Endocrinol. 2015. PMID: 26291795 Review.
Hyperprolactinemia is a typical condition producing reproductive dysfunction in both sexes, resulting in hypogonadism, infertility and galactorrhea. It may be also asymptomatic. ...
Hyperprolactinemia is a typical condition producing reproductive dysfunction in both sexes, resulting in hypogonadism, infertility an …
Olfactory receptor function.
Glezer I, Malnic B. Glezer I, et al. Handb Clin Neurol. 2019;164:67-78. doi: 10.1016/B978-0-444-63855-7.00005-8. Handb Clin Neurol. 2019. PMID: 31604564 Review.
Damage to this epithelium can be caused by multiple factors, leading to anosmia (smell loss). In this chapter, we introduce the basic organization of the OE and focus on the molecular mechanisms involved in odorant perception. ...
Damage to this epithelium can be caused by multiple factors, leading to anosmia (smell loss). In this chapter, we introduce the basic …
860 results